A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI 2) trial suggested that the distributions of MBL genotypes were similar to those known in the general population [25]. Here, INS is linked to acute myocardial infarction.